Surmodics reported $0 in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Anika Therapeutics ANIK:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
Baxter International BAX:US $ 5446M 264M
Bioscrip BIOS:US $ 1117.82M 1.64M
Cryolife CRY:US $ 307.76M 5.14M
Edap Tms EDAP:US $ 5.27M 0.06M
Genmark Diagnostics GNMK:US $ 71.3M 0.55M
Haemonetics HAE:US $ 698.04M 69.3M
Merit Medical Systems MMSI:US $ 271.18M 13.72M
Mesa Laboratories MLAB:US $ 168.92M 0.22M
Nektar Therapeutics NKTR:US $ 0M 0M
Oxford Immunotec Global OXFD:US $ 0M 0M
Providence Service PRSC:US $ 974.67M 487.24M
Stryker SYK:US $ 12629M 105M
Trinity Biotech TRIB:US $ 0M 84.04M